MDMA.CN
Price:
$0.11
Market Cap:
$11.57M
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Industry
Biotechnology
IPO Date
2022-01-11
Stock Exchange
CNQ
Ticker
MDMA.CN
According to Pharmala Biotech Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.50. This represents a change of -31.35% compared to the average of -8.01 of the last 4 quarters.
The mean historical PE Ratio of Pharmala Biotech Holdings Inc. over the last ten years is -9.96. The current -5.50 PE Ratio has changed 5.42% with respect to the historical average. Over the past ten years (40 quarters), MDMA.CN's PE Ratio was at its highest in in the November 2023 quarter at 56.31. The PE Ratio was at its lowest in in the August 2023 quarter at -58.96.
Average
-9.96
Median
-6.68
Minimum
-23.85
Maximum
-2.65
Discovering the peaks and valleys of Pharmala Biotech Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 466.35%
Maximum Annual PE Ratio = -2.65
Minimum Annual Increase = -61.67%
Minimum Annual PE Ratio = -23.85
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -9.14 | -61.67% |
| 2023 | -23.85 | 466.35% |
| 2022 | -4.21 | 59.11% |
The current PE Ratio of Pharmala Biotech Holdings Inc. (MDMA.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.40
5-year avg
-9.96
10-year avg
-9.96
Pharmala Biotech Holdings Inc.’s PE Ratio is less than Marvel Biosciences Corp. (-3.71), greater than PharmaTher Holdings Ltd. (-6.31), less than BetterLife Pharma Inc. (-3.64), less than Red Light Holland Corp. (-2.82), greater than Medicure Inc. (-8.56), less than Hemostemix Inc. (-3.17), greater than Comprehensive Healthcare Systems, Inc. (-5.55), less than Glow Lifetech Corp. (-4.12), less than Britannia Life Sciences Inc. (1.78), less than PreveCeutical Medical Inc. (-3.72),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.71 | $8.99M | |
| -6.31 | $10.01M | |
| -3.64 | $7.59M | |
| -2.82 | $10.56M | |
| -8.56 | $11.58M | |
| -3.17 | $17.67M | |
| -5.55 | $8.62M | |
| -4.12 | $9.96M | |
| 1.78 | $14.60M | |
| -3.72 | $11.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmala Biotech Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmala Biotech Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pharmala Biotech Holdings Inc.'s PE Ratio?
How is the PE Ratio calculated for Pharmala Biotech Holdings Inc. (MDMA.CN)?
What is the highest PE Ratio for Pharmala Biotech Holdings Inc. (MDMA.CN)?
What is the 3-year average PE Ratio for Pharmala Biotech Holdings Inc. (MDMA.CN)?
What is the 5-year average PE Ratio for Pharmala Biotech Holdings Inc. (MDMA.CN)?
How does the current PE Ratio for Pharmala Biotech Holdings Inc. (MDMA.CN) compare to its historical average?